05.18.2009 | Investors

Watson Promotes Patricia Eisenhaur to VP Investor Relations and Corporate Communications

CORONA, CA, May 18, 2009 (MARKETWIRE via COMTEX) -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced the promotion of Patricia L. Eisenhaur, 46, to Vice President, Investor Relations and Corporate Communications.

"Since joining the company, Patty has played a key role in building our investor relations function and raising Watson's visibility with shareholders, analysts and the media," said Paul Bisaro, Watson's President and Chief Executive Officer. "She brings unique qualities and a wealth of experience in a wide variety of communications which will serve us well as we position ourselves for further growth."

Ms. Eisenhaur joined Watson in 2001 as Director, Investor Relations and most recently was Executive Director Investor Relations. Prior to her tenure at Watson, Ms. Eisenhaur spent five years at ALZA Corporation (a Johnson & Johnson Company), in various investor relations positions of increasing responsibility. Ms. Eisenhaur will be transitioning to the company's Morristown, NJ location.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Watson Pharmaceuticals, Inc.
Patty Eisenhaur
(951) 493-5611

SOURCE: Watson Pharmaceuticals

Media Contacts
Amy Rose
Global Corporate Media Relations
+1 (862) 289 3072
Lisa Brown
Global Corporate Media Relations
+1 (862) 261 7320
Fran DeSena
U.S. Product Media Relations
+1 (862) 261 8820
Mark Marmur
International Communications & Public Relations
+44 7725 758677

For local media contacts in other countries, please visit the relevant country website.

Investor relations:

Karina Calzadilla
Investor Relations
+1 (862) 261 7488